Whalegun
Home

Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 01/20

Trade details

Type
Insider sale
Amount
$1,849,500.94
Shares · price
136,193 sh · $13.58 a share
Held after
3,378,546 sh
Stock
Amylyx Pharmaceuticals AMLX
Person
Justin B. KleeCo-CEO
Trade date
26/01/15
Filed
26/01/20
Days to filing
5 days

Sold 3.9% of holdings

Share of holding sold
3.9%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/16~02/14

Justin B. Klee's recent trades

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $980.3K

    Filed 09/11

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $423.7K

    Filed 03/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $423.8K

    Filed 03/02

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $227.7K

    Filed 02/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $227.6K

    Filed 02/02

Justin B. Klee, CEO — sold $1.8M of Amylyx Pharmaceuticals AMLX · 3.9% of holdings | Whalegun